Paramount Global Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $226.60 million. The enterprise value is $302.05 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 70.37 million shares outstanding. The number of shares has increased by 12.46% in one year.
| Current Share Class | 70.37M |
| Shares Outstanding | 70.37M |
| Shares Change (YoY) | +12.46% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 3.38% |
| Owned by Institutions (%) | 80.29% |
| Float | 67.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.93 |
| PS Ratio | 0.66 |
| Forward PS | 0.63 |
| PB Ratio | 0.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.83 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.97 |
Financial Efficiency
Return on equity (ROE) is -28.42% and return on invested capital (ROIC) is -5.80%.
| Return on Equity (ROE) | -28.42% |
| Return on Assets (ROA) | -4.99% |
| Return on Invested Capital (ROIC) | -5.80% |
| Return on Capital Employed (ROCE) | -10.10% |
| Revenue Per Employee | $210,729 |
| Profits Per Employee | -$66,746 |
| Employee Count | 1,500 |
| Asset Turnover | 0.48 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $446,000 in taxes.
| Income Tax | 446,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.37% in the last 52 weeks. The beta is 1.46, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -49.37% |
| 50-Day Moving Average | 3.79 |
| 200-Day Moving Average | 5.24 |
| Relative Strength Index (RSI) | 41.72 |
| Average Volume (20 Days) | 807,561 |
Short Selling Information
The latest short interest is 3.91 million, so 5.55% of the outstanding shares have been sold short.
| Short Interest | 3.91M |
| Short Previous Month | 3.74M |
| Short % of Shares Out | 5.55% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 8.60 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $316.09 million and -$100.12 million in losses. Loss per share was -$1.53.
| Revenue | 316.09M |
| Gross Profit | 145.41M |
| Operating Income | -52.26M |
| Pretax Income | -86.06M |
| Net Income | -100.12M |
| EBITDA | -17.90M |
| EBIT | -52.26M |
| Loss Per Share | -$1.53 |
Full Income StatementBalance Sheet
The company has $97.34 million in cash and $172.79 million in debt, giving a net cash position of -$75.45 million or -$1.07 per share.
| Cash & Cash Equivalents | 97.34M |
| Total Debt | 172.79M |
| Net Cash | -75.45M |
| Net Cash Per Share | -$1.07 |
| Equity (Book Value) | 347.55M |
| Book Value Per Share | 4.95 |
| Working Capital | 81.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.04 million and capital expenditures -$1.56 million, giving a free cash flow of -$7.59 million.
| Operating Cash Flow | -6.04M |
| Capital Expenditures | -1.56M |
| Free Cash Flow | -7.59M |
| FCF Per Share | -$0.11 |
Full Cash Flow StatementMargins
Gross margin is 46.00%, with operating and profit margins of -16.53% and -31.67%.
| Gross Margin | 46.00% |
| Operating Margin | -16.53% |
| Pretax Margin | -31.53% |
| Profit Margin | -31.67% |
| EBITDA Margin | -5.66% |
| EBIT Margin | -16.53% |
| FCF Margin | n/a |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.46% |
| Shareholder Yield | -12.46% |
| Earnings Yield | -44.18% |
| FCF Yield | -3.35% |
Analyst Forecast
The average price target for Health Catalyst is $6.18, which is 91.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.18 |
| Price Target Difference | 91.93% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 11.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -1.59 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.59 |
| Piotroski F-Score | 4 |
